Moderna, Samsung Biologics sign agreement for fill-finish manufacturing of COVID-19 vaccine
The agreement will further enable global supply of mRNA-1273, Moderna’s COVID-19 vaccine with Samsung Biologics’ fill and finish…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.